Company: NEOG
Filing Date: 2025-01-15
Form Type: 10-Q
Source: 0000950170-25-005818
Chunk: 81

Company: NEOGEN CORP
Filing Date: 2025-01-15
Form: 10-Q
Item: Item 1A
Chunk 81
---
This Form 10-Q should be read in conjunction with Part I Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended May 31, 2024. There have been no material changes in the risk factors described in our Annual Report on Form 10-K for the year ended May 31, 2024. 

28

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

In October 2018, the Company’s Board of Directors authorized a program to purchase, subject to market conditions, up to 6,000,000 shares of the Company’s common stock. The program does not have any scheduled expiration date.  As of November 30, 2024, a total of 5,900,000 shares of common stock remained available for repurchase under this program. The following is a summary of share repurchase activity during the fiscal quarter ended November 30, 2024:

    Period
     
    Shares Purchased

    Average Price Paid per Share

    Shares Purchased as Part of Publicly Announced Plans or Programs

    Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs

    September 2024

    —

    —

    —

    5,900,000

    October 2024

    —

    —

    —

    5,900,000

    November 2024

    —

    —

    —

    5,900,000

    Total

    —

    —

    —

    5,900,000

Items 3 and 4 are not applicable or removed or reserved and have been omitted. 

Item 5.  Other Information 

During the quarterly period ended November 30, 2024, no director or officer (as defined in SEC Rule 16a-1(f)) of the Company adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K).

29

Item 6. Exhibits 

(a) Exhibit Index

      31.1
    Certification of Principal Executive Officer 

      31.2
    Certification of Chief Financial Officer 

      32
    Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    101.INS